Latest Content

Gleevec Associated With Long-Term Effectiveness in Treating GIST

September 17th 2025, 7:00pm

By Alex Biese

Article

For patients with advanced GIST Gleevec, complete surgical removal of metastasis and complete Gleevec response are associated with survival time doubling.

The Days of a Breast Cancer Survivor

September 17th 2025, 5:00pm

By Laura Yeager

Article

Having been through two bouts of breast cancer, I am happy to be on this planet with my family, friends and neighbors.

Prostate Cancer Survivor Encourages Men to Speak Up and Get Tested

September 17th 2025, 4:00pm

By Ryan Scott

Article

Bob Lane, a prostate cancer survivor, discusses the stigma men often feel when talking about prostate cancer.

Ligufalimab Gains FDA Orphan Drug Status for Acute Myeloid Leukemia

September 17th 2025, 3:10pm

By Spencer Feldman

Article

The FDA granted orphan drug designation to ligufalimab for AML, reflecting its potential as an immune-based therapy that may offer new options for patients.

Expert Highlights Importance of Understanding Myelofibrosis Treatments

September 17th 2025, 1:00pm

By Dr. Prithviraj Bose

Video

Dr. Prithviraj Bose discusses how patients with myelofibrosis can better understand their options and access the most up-to-date advancements in care.

What the Changing Seasons Taught Me About Cancer and Life

September 16th 2025, 9:00pm

By Tamron Little

Article

The first day of fall comes on September 22, and every year it feels like a reminder to pause.

Understanding the Importance of Biomarker Testing in Lung Cancer

September 16th 2025, 8:00pm

By Dr. Joshua K. Sabari

Video

Dr. Joshua K. Sabari sat down with Terri Conneran at the 2025 World Conference on Lung Cancer for a conversation on the importance of biomarker testing.

How to Individually Tailor Myelofibrosis Treatment Options

September 16th 2025, 7:00pm

By Ryan Scott

Article

Dr. Prithviraj Bose explains how doctors tailor myelofibrosis treatments and how patients can work with their care teams to navigate options.

A Day in the Life of a Breast Cancer Survivor

September 16th 2025, 5:00pm

By Bonnie Annis

Article

Since being diagnosed with breast cancer, my life has drastically changed. Time has helped each day become more precious and has caused me to become more grateful.

Jakafi for Myelofibrosis Associated With Skin Cancer, Shingles Risk

September 16th 2025, 4:00pm

By Alex Biese

Article

For patients with myelofibrosis, there is a risk of non-melanoma skin cancer or shingles among patients who received long-term treatment with Jakafi.

FDA Grants Designation to Investigational Drug for Head and Neck Cancer

September 16th 2025, 3:00pm

By Ryan Scott

Article

The FDA has granted fast track designation to the investigational drug CRB-701 for recurrent or metastatic head and neck squamous cell carcinoma.

Can Anemia or Bleeding Be a Sign of Gastrointestinal Stromal Tumors?

September 16th 2025, 1:00pm

By Dr. Rosario Ligresti

Video

Dr. Rosario Ligresti explained that while many GISTs are found incidentally, larger tumors may cause anemia, bleeding or swallowing issues.

Thanking My Support System From My Cancer Journey

September 15th 2025, 9:00pm

By Carla Deschamps

Article

Five years after being diagnosed with colon cancer, I would like to share how my support system continues to play a role in my life after active treatment.

Ibtrozi May Address Unmet Needs In ROS1-Positive Non-Small Cell Lung Cancer

September 15th 2025, 8:00pm

By Dr. Geoffrey Liu

Video

Dr. Geoffrey Liu discussed findings from the phase 2 TRUST-II clinical trial evaluating Ibtrozi (taletrectinib) among patients with ROS1-positive non-small cell lung cancer.

Actively Recruiting Trials for Lung, Biliary, AML and Small Cell Cancer

September 15th 2025, 7:00pm

By Spencer Feldman

Article

Early trial results report progression-free survival and response rates for ateganosine, spevatamig, Annamycin and pumitamig; studies are currently enrolling.